Prestige Consumer Healthcare Inc.
Financial highlights
| Metric | FY 03/31/26 | FY 03/31/25 | FY 03/31/24 | FY 03/31/23 | FY 03/31/22 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B |
| Cost of revenue | $493.1M | $503.3M | $500.9M | $502.4M | $466.2M |
| Gross profit | $595.6M | $634.5M | $624.4M | $625.3M | $620.6M |
| Operating expenses | $286.2M | $297.7M | $282.0M | $647.7M | $290.7M |
| Operating income | $309.4M | $336.8M | $342.4M | -$22.4M | $329.9M |
| Interest expense | — | $1.8M | $5.2M | $4.4M | — |
| Pretax income | $257.5M | $284.2M | $276.0M | -$93.9M | $262.5M |
| Income tax expense | $67.2M | $69.6M | $66.7M | -$11.6M | $57.1M |
| Net income | $190.3M | $214.6M | $209.3M | -$82.3M | $205.4M |
| Balance Sheet | |||||
| Cash and equivalents | $63.9M | $97.9M | $46.5M | $58.5M | $27.2M |
| Current assets | $431.5M | $448.3M | $375.0M | $391.7M | $293.3M |
| Total assets | $3.5B | $3.4B | $3.3B | $3.4B | $3.7B |
| Current liabilities | $120.9M | $106.6M | $117.0M | $160.7M | $143.4M |
| Total liabilities | $1.6B | $1.6B | $1.7B | $1.9B | $2.1B |
| Total debt | $1.0B | $1.0B | $1.1B | $1.4B | $1.5B |
| Stockholders' equity | $1.9B | $1.8B | $1.7B | $1.4B | $1.6B |
| Cash Flow Statement | |||||
| Cash from operations | $257.6M | $251.5M | $248.9M | $229.7M | $259.9M |
| Depreciation and amortization | $31.3M | $30.2M | $30.7M | $32.6M | $32.1M |
| Stock-based compensation | $10.8M | $11.2M | $14.0M | $12.4M | $9.0M |
| Capital expenditure | $11.2M | $8.2M | $9.6M | $7.8M | $9.6M |
| Free cash flow | $246.4M | $243.3M | $239.4M | $221.9M | $250.3M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Share repurchases | $156.3M | $51.5M | $25.0M | $50.0M | $0 |
| Impairments | $0 | $12.5M | $0 | $370.2M | $1.1M |
Shares outstanding 47.3M · Free float 98.5%
Annual filing data through FY ended March 31, 2026; float as of July 4, 2026.